Patient Guide: Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 42 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05609630
Status: 🟢 Enrolling Now
Condition: Juvenile Idiopathic Arthritis
Phase: PHASE3

Where You Can Participate

This study is available at 42 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Valhalla, New York
  • • Charlotte, North Carolina
  • • And 39 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. - Join Clinical Trial NCTNCT05609630

How to Join This Clinical Trial - NCTNCT05609630

Learn how to participate in this PHASE3 trial studying an investigational therapy for Juvenile Idiopathic Arthritis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Juvenile Idiopathic Arthritis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Juvenile Idiopathic Arthritis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05609630 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 42 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85016-7710 - United States

Status: RECRUITING

Clinical Research Site

Valhalla, New York 10595 - United States

Status: RECRUITING

Clinical Research Site

Charlotte, North Carolina 28203 - United States

Status: RECRUITING

Clinical Research Site

Cincinnati, Ohio 45229 - United States

Status: RECRUITING

Clinical Research Site

Portland, Oregon 97227-1654 - United States

Status: RECRUITING

Clinical Research Site

Rosario, Santa Fe 2000 - Argentina

Status: RECRUITING

Clinical Research Site

San Miguel de Tucuman, Tucuman 4000 - Argentina

Status: RECRUITING

Clinical Research Site

Clayton, Victoria 3168 - Australia

Status: RECRUITING

Clinical Research Site

Parkville, Victoria 3052 - Australia

Status: RECRUITING

Clinical Research Site

Bregenz, Vorarlberg 6900 - Austria

Status: RECRUITING

And 32 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Juvenile Idiopathic Arthritis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships